The Company is a specialty pharmacy with a focus on infused and injected products. It was started by a husband and wife team who had grown the business very successfully for more than a decade.
Due to the public profile of one of the owners, confidentiality was of the highest importance. Trestle worked with the Company to scope a process that was targeted to ensure confidentiality but included a mix of both highly qualified strategic suitors and healthcare focused equity sponsors.
The process resulted in multiple proposals from both strategic suitors and equity sponsors. The Company ultimately chose an offer from a strategic acquiror that was in the process of filing for an initial public stock offering. The owners received compensation both in the form of cash and in pre-IPO stock that held significant potential for growth once the acquiring company went public.